Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03294590 · ClinicalTrials.gov registry record · NA

Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children

A NA study, sponsored by Boston University.

Completed
Registry status
NA
Development phase
754
Enrollment target

NCT03294590: Completed NA study, sponsored by Boston University.

NCT03294590 is a NA study that has completed, run by Boston University. The registered enrollment target is 754 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03294590, a NA study, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
754 participants
Enrollment target

Study Summary

This is a randomized clinical trial to test the efficacy of a parent-targeted text message-based intervention program on caries incidence and oral health behaviors (child and parent). Parents (n= 850) across all pediatric clinic sites (Boston Medical Center and Community Health Centers (CHCs); DotHouse CHC, South End Community Health Center, and Codman Square CHC) will be randomized to receive either text messages (TMs) regarding oral health or TMs regarding child wellness. The study will enroll English and Spanish speaking parents and their youngest child who is \< 7 years old, has at least one tooth showing, and attends the targeted pediatric clinic to receive primary care (n= 1700). Parents will complete self-report surveys at baseline, and 2, 4, 12, and 24-months after baseline; receive and respond to TM assessments during the 4-month intervention; and will also receive TMs during a 'booster' period of one month, which will occur 12-months post baseline. Parent's children will be assessed for caries by a clinical oral examination performed by licensed Clinical Examiners at baseline, 12-and-24-months post-baseline.

Primary Outcome

Surface level caries data in children was collected by calibrated clinical examiners (blind to treatment condition), utilizing the OHDC Modified ICDAS methodology, will allow calculation of caries increment (development of a new cavitated lesion or filled surface on a previously sound tooth surface).

Interventions

  • OTHER OHT Parent targeted text messages
  • OTHER CWT Parent targeted text messages

Trial Details

FieldValue
Enrollment Target 754 participants
Start Date 2018-03-09
Est. Completion 2022-02-28
Phase NA
Boston University

185 total trials

What the finished NCT03294590 record still lists

NCT03294590 is an interventional study that assigns participants to a tested intervention. The registered 754 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).

The record links to 0 conditions, and to 2 interventions - of which OHT Parent targeted text messages is the first listed.

NCT03294590 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03294590 about?

NCT03294590 is a clinical study titled "Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children". This is a randomized clinical trial to test the efficacy of a parent-targeted text message-based intervention program on caries incidence and oral health behaviors (child and parent). Parents (n= 850) across all pediatric clinic sites (Boston Medical Center and Community Health Centers (CHCs); DotHo...

What is the current status of trial NCT03294590?

This trial is currently completed. It is a NA study. The enrollment target is 754 participants. The study started on 2018-03-09. Estimated completion is 2022-02-28.

What interventions are being tested in trial NCT03294590?

The interventions under investigation include: OHT Parent targeted text messages (OTHER), CWT Parent targeted text messages (OTHER).

Who is sponsoring clinical trial NCT03294590?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03294590's enrollment target sits among peer trials

754 145th of 2000 higher than 1,856 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05379985 · 754 participants · Phase 1

    Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • NCT05427370 · 754 participants · NA

    The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

  • NCT05869149 · 756 participants · NA

    Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial

  • NCT06095583 · 756 participants · Phase 3

    Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03294590, the US trial registry maintained by the National Library of Medicine. NCT03294590 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.